I agree that this site is using cookies. You can find further informations here.
X
Chamoun, Kamal
26  results:
Articles (Online) X
Search for persons X
?
1

POSTER: MPN-336 Selinexor Plus Ruxolitinib in JAK Inhibitor..:

Ali, Haris ; Kishtagari, Ashwin ; Maher, Keri...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S195 , 2023
Link: https://doi.org/10.1016/..
 
?
2

MPN-336 Selinexor Plus Ruxolitinib in JAK Inhibitor (JAKi) ..:

Ali, Haris ; Kishtagari, Ashwin ; Maher, Keri...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S389 , 2023
Link: https://doi.org/10.1016/..
 
?
3

P1020: SELINEXOR (SEL) PLUS RUXOLITINIB (RUX) IN JAK INHIBI..:

Ali, Haris ; Kishtagari, Ashwin ; Maher, Keri...
HemaSphere.  7 (2023)  S3 - p. e402391a , 2023
Link: https://doi.org/10.1097/..
 
?
4

The Association between Patient Characteristics and the Eff..:

Zijlstra, Josée M. ; Follows, George ; Casasnovas, Rene-Olivier...
Cancers.  14 (2022)  3 - p. 791 , 2022
Link: https://doi.org/10.3390/..
 
?
5

Comparison of the Effectiveness and Safety of the Oral Sele..:

Casasnovas, Rene-Olivier ; Follows, George ; Zijlstra, Josee M....
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  1 - p. 24-33 , 2022
Link: https://doi.org/10.1016/..
 
?
6

Effect of Prior Therapy and Disease Refractoriness on the E..:

Schuster, Michael ; Zijlstra, Josée ; Casasnovas, Rene-Olivier...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  7 - p. 483-494 , 2022
Link: https://doi.org/10.1016/..
 
?
7

Oral eltanexor treatment of patients with higher-risk myelo..:

Lee, Sangmin ; Mohan, Sanjay ; Knupp, Jessica...
Journal of Hematology & Oncology.  15 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
?
8

Survival among patients with relapsed/refractory diffuse la..:

Maerevoet, Marie ; Zijlstra, Josee M. ; Follows, George...
Journal of Hematology & Oncology.  14 (2021)  1 - p. , 2021
Link: https://doi.org/10.1186/..
 
?
9

Socioeconomic Factors and Survival of Multiple Myeloma Pati..:

Chamoun, Kamal ; Firoozmand, Amin ; Caimi, Paolo...
Cancers.  13 (2021)  4 - p. 590 , 2021
Link: https://doi.org/10.3390/..
 
?
10

A case of neurocognitive deficit strongly related to dasati..:

Chamoun, Kamal ; Rabinovich, Emma ; Baer, Linda..
Hematology, Transfusion and Cell Therapy.  42 (2020)  1 - p. 80-82 , 2020
Link: https://doi.org/10.1016/..
 
?
11

Tyrosine kinase inhibitor discontinuation in patients with ..:

Chamoun, Kamal ; Kantarjian, Hagop ; Atallah, Rami...
Journal of Hematology & Oncology.  12 (2019)  1 - p. , 2019
Link: https://doi.org/10.1186/..
 
?
12

Allogeneic Transplantation after Myeloablative Rituximab/BE..:

Chamoun, Kamal ; Milton, Denái R. ; Ledesma, Celina...
Biology of Blood and Marrow Transplantation.  25 (2019)  7 - p. 1347-1354 , 2019
Link: https://doi.org/10.1016/..
 
?
13

Oral Vs Intravenous Tacrolimus Post Allogeneic Stem Cell Tr..:

Chamoun, Kamal ; Getz, Theodore ; Kolk, Merle...
Biology of Blood and Marrow Transplantation.  25 (2019)  3 - p. S117-S118 , 2019
Link: https://doi.org/10.1016/..
 
?
14

Peri-Transplant Venous Thromboembolism in Patients with Mul..:

Chamoun, Kamal ; Covut, Fahrettin ; Park, Michelle...
Biology of Blood and Marrow Transplantation.  25 (2019)  3 - p. S404-S405 , 2019
Link: https://doi.org/10.1016/..
 
?
15

Unrecognized fluid overload during induction therapy increa..:

Chamoun, Kamal ; Kantarjian, Hagop M. ; Wang, Xuemei...
Cancer.  125 (2019)  18 - p. 3219-3224 , 2019
Link: https://doi.org/10.1002/..
 
1-15